SCHEMBL6635707

SCHEMBL6635707

O=C(Nc1ccccc1O)c1ccco1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ HDAC1 Q13547 1/20 0.67
▸ GAA P10253 5/20 0.66
▸ NPC1 O15118 2/20 0.66
▸ KCNMA1 Q12791 1/20 0.66
▸ TP53 P04637 1/20 0.66
▸ TSHR P16473 1/20 0.65
▸ MAPT P10636 5/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ ESR2 Q92731 1/20 0.64
▸ RAB9A P51151 3/20 0.62
▸ MAPK1 P28482 1/20 0.61
▸ ATM Q13315 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ RECQL P46063 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ HTT P42858 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14096453 0.85 KMT2A (0.76) SMN1; SMN2KMT2AGAANPC1MAPT
SCHEMBL30587183 0.81 SMN1; SMN2 (1.00) SMN1; SMN2KMT2AGAANPC1TSHR
SCHEMBL1520253 0.81 KMT2A (0.67) SMN1; SMN2KMT2AGAANPC1TP53
SCHEMBL6632751 0.81 RAB9A (0.74) SMN1; SMN2KMT2ANPC1KCNMA1TP53
SCHEMBL30117825 0.81 RAB9A (0.74) SMN1; SMN2KMT2ANPC1KCNMA1TP53
SCHEMBL6638142 0.81 ATM (0.77) SMN1; SMN2KMT2AGAATSHRMAPT
SCHEMBL6633552 0.81 SMN1; SMN2 (1.00) SMN1; SMN2KMT2AGAANPC1TSHR
SCHEMBL15528812 0.80 MAPK1 (0.71) SMN1; SMN2KMT2AGAANPC1TSHR
SCHEMBL13212283 0.80 KMT2A (0.65) SMN1; SMN2KMT2AGAANPC1TP53
SCHEMBL13219539 0.80 KCNMA1 (0.79) SMN1; SMN2KMT2AGAANPC1KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1442041-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-08-04 — — EP claimed
WO-2003040147-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE__________________________________________________________________________________________________________________________ PHARMACIA & UPJOHN COMPANY (US) 2003-05-15 — — WO claimed
EP-1442041-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-08-04 — — EP disclosed
WO-2003040147-A1 AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE__________________________________________________________________________________________________________________________ PHARMACIA & UPJOHN COMPANY (US) 2003-05-15 — — WO disclosed
EP-0443045-B1 HEAT-SENSITIVE SUBLIMATION TRANSFER CYAN DYE AND TRANSFER SHEET MITSUI TOATSU CHEMICALS (JP) 1995-01-11 — — EP disclosed
US-5183474-A HEAT-SENSITIVE SUBLIMATION TRANSFER CYAN DYE AND TRANSFER SHEET MITSUI TOATSU CHEMICALS INC. (JP) 1993-02-02 — — US disclosed
EP-0443045-A1 HEAT-SENSITIVE SUBLIMATION TRANSFER CYAN DYE AND TRANSFER SHEET MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-08-28 — — EP disclosed
Send feedback